1. HIV Prevention 2020: a framework for delivery and a call for action
Dr Karl L Dehne, PhD, Gina Dallabetta, MD, David Wilson, PhD, Prof Geoff P Garnett, PhD, Prof Marie Laga, PhD, Elizabeth Benomar, MBA, Ade Fakoya, PhD, Rachel C Baggaley, MBBS, Lisa J Nelson, MD, Susan Kasedde, PhD, Alvaro Bermejo, MD, Mitchell Warren, PhD, Clemens Benedikt, PhD 
The Lancet HIV 
Volume 3, Issue 7, Pages e323-e332 (July 2016)
DOI: /S (16)
Copyright © 2016 Elsevier Ltd Terms and Conditions

2. Figure 1 Core results for HIV prevention by 2020
ART=antiretroviral therapy. NSP=needle syringe programme. OST=opioid substitution therapy. PrEP=pre-exposure prophylaxis.
The Lancet HIV 2016 3, e323-e332DOI: ( /S (16) )
Copyright © 2016 Elsevier Ltd Terms and Conditions

3. Figure 2 A management framework for HIV prevention
ART=antiretroviral therapy.
The Lancet HIV 2016 3, e323-e332DOI: ( /S (16) )
Copyright © 2016 Elsevier Ltd Terms and Conditions

4. Figure 3
Core capacities needed in a national HIV prevention management team
The Lancet HIV 2016 3, e323-e332DOI: ( /S (16) )
Copyright © 2016 Elsevier Ltd Terms and Conditions